Affiliation:
1. Department of Neurology, Sun Yat-sen Memorial Hospital, Sun Yat-sen University, 107 Yanjiang West Road, Guangzhou, 510120, China
Abstract
Glioblastoma Multiforme (GBM) is the most frequent glioma with a poor prognosis.
The mainstay treatment for GBM is chemotherapy, but the average survival of GBM remains
unsatisfactory due to therapeutic resistance. Poor permeability restricted by the Blood
Brain Barrier (BBB) and the presence of Glioblastoma Stem Cells (GSCs) remain as two
problems for chemotherapy. Recently, nanocarriers have attracted much attention in the research
of GBM, owing to their advantages in self-assembly, biosafety, release controllability,
and BBB penetrability, making them promising candidates for GBM treatment. This article
aims to review the biologic signatures of BBB and GSCs, as well as the new development of
nano-drug delivery systems to facilitate our understanding of targeted treatment for GBM.
Funder
Guangzhou Science Technology and Innovation Commission
National Natural Science Foundation of China
Publisher
Bentham Science Publishers Ltd.
Subject
Pharmacology,Molecular Medicine,Drug Discovery,Biochemistry,Organic Chemistry
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献